9654 Sparta Ave NW, Sparta, MI 49345, (616) 887-7389

http://www.facebook.com/KnowltonMcFallDentistry

ViziLite Plus is an oral cancer screening exam that assists dental professionals in the early detection of oral abnormalities including premalignant lesions and oral cancer. Early detection saves lives. When oral cancer is found early, treatment is 90% successful. The ViziLite Plus exam improves the examiner's ability to identify, evaluate and monitor abnormal areas that are difficult or impossible to see under conventional lighting.

In our continuing efforts to provide the most advanced technology and highest standard of care available to our patients, our practice is proud to use ViziLite Plus exams as an integral part of our annual comprehensive oral screening program.

One person dies every hour from oral cancer in the United States - and the mortality rate has remained unchanged for more than 40 years. On the other hand, mortality rates have drastically decreased for cervical cancer, breast cancer, prostate cancer, and colon cancer primarily due to the introduction of screening exams (Pap smear, mammogram, PSA test, and colonoscopy respectively). Since the introduction of the Pap smear in 1952, there has been an 80% reduction in deaths from cervical cancer, and since the introduction of mammography in 1972, there has been a 45% reduction in deaths from breast cancer. Oral cancer is very deadly. 40% of patients diagnosed with oral cancer from the traditional exams that we have used up until now, die within 5 years. However, that will begin changing now with screening using the ViziLite system that can detect the oral cancer in stage 1 or 2 (that has a 90% survival rate) rather than the examination alone that detects oral cancer in stage 3 and 4 with only a 60% survival rate.

In the past, patients that we considered at increased risk for oral cancer were patients over 40 and/or those patients who used tobacco. With the introduction of the human papilloma virus (HPV), that has changed. HPV is suspected to contribute to 20%-30% of oral cancer cases. Anyone sexually active is at risk for HPV and therefore is at an increased risk for oral cancer. The medical and dental community now considers anyone 18 and over at risk for oral cancer. The American Dental Association is recommending, and we are prescribing, the ViziLite screening exam for everyone 18 years and older.

ViziLite Plus is an easy and painless screening examination that gives this practice the best chance to find any oral abnormal lesions. Dental insurance might not cover this advanced oral cancer screening as an addition to the standard visual examination. We will be performing the ViziLite Plus exam annually following the standard oral cancer examination of the oral cavity for a fee of $49.